Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Acute interstitial nephritis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Komanduri K, et al. A Case of Acute Interstitial Nephritis Secondary to Novel HCV Treatment Paritaprevir/Ritonavir/Ombitasvirf/Dasabuvir (PrOD). Journal of the American Society of Nephrology 27: 1033A, Nov 2016 [abstract] Komanduri K, et al. A Case of Acute Interstitial Nephritis Secondary to Novel HCV Treatment Paritaprevir/Ritonavir/Ombitasvirf/Dasabuvir (PrOD). Journal of the American Society of Nephrology 27: 1033A, Nov 2016 [abstract]
Metadaten
Titel
Dasabuvir/ombitasvir/paritaprevir/ritonavir
Acute interstitial nephritis: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45222-1

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Carvedilol